News & Trends - MedTech & Diagnostics
Stryker launches limited-release medical bed to support critical needs during COVID-19 pandemic
MedTech News: Stryker has developed a low-cost, limited-release emergency response bed to quickly aid healthcare providers with efficient care during the COVID-19 pandemic.
Stryker anticipates producing 10,000 beds a week to meet increased needs.
Stryker’s Emergency Relief Bed is a low-cost, readily available solution intended to serve those on the front lines – ranging from hospital emergency departments to triage and pop-up areas of care. It includes a six-inch-thick foam surface.
The Emergency Relief Bed features a 30-degree head of bed angle to accommodate patients in respiratory distress, including ventilated patients. It also features low height and an attached IV pole.
“People are at the heart of what we do, and COVID-19 hasn’t changed that. It has amplified our mission of making healthcare better. We’re focused on meeting the supply needs of our customers so they can focus on taking care of patients right now. That’s why we raced to develop our Emergency Relief Bed, which will help emergency responders and caregivers move and position patients efficiently during this critical time,” said Brad Saar, president of Stryker’s Medical division.
The bed is intended for use in the COVID-19 pandemic to support increased patient numbers in healthcare facilities. Stryker is actively pursuing making the bed available in select markets around the world.
Digital & Innovation
Meta finally admits to exploiting Aussie data for AI training: Call for privacy law reforms
Digital & Innovation: Facebook uses photos, posts and data from its adult Australian users to train AI models, Meta’s global […]
MoreNews & Trends - MedTech & Diagnostics
Policymakers undergo diabetes health check as push for equitable access to medical technologies escalates
MedTech News: Policymakers at Parliament House underwent a comprehensive health check yesterday, including assessments for HbA1c, cholesterol, blood pressure, and […]
MoreNews & Trends - Pharmaceuticals
Diabetes drugs underused in Australia despite proven benefits, study reveals
Pharma News: A new analysis has revealed that more Australians with type 2 diabetes should have access to potentially lifesaving […]
MoreNews & Trends - MedTech & Diagnostics
Landmark funding to expand genomic testing and precision medicine access for Victorian cancer patients
Diagnostics News: A landmark funding contribution will establish an advanced genomic testing program in Victoria, aiming to deliver personalised, precision […]
More